Want to see IN:ASTERDM full AI Analyst Report?
Top Page
Aster DM Healthcare Ltd.
(ASTERDM)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹803.00
▲(30.53% Upside)
Action:Reiterated
Date:08/06/26
The score is primarily supported by improving but still inconsistent financial performance (better margins, lower leverage, and positive FY2026 free cash flow, offset by volatility in earnings quality and cash conversion). Technicals add support with a clear uptrend and positive momentum, while the overall score is held back by demanding valuation (very high P/E and low dividend yield).
Positive Factors
Revenue Growth
Positive revenue growth indicates continued demand for Aster’s hospitals, clinics, diagnostics and pharmacy services. Sustained patient volumes and healthcare utilization can support operating leverage and provide a durable base for expansion across its care network.
Negative Factors
Earnings Volatility
The sharp FY2025 profit and margin spike, alongside earlier revenue declines, makes underlying earnings quality harder to assess. Inconsistent results may reduce forecasting confidence and complicate decisions on capacity expansion and resource allocation.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Positive revenue growth indicates continued demand for Aster’s hospitals, clinics, diagnostics and pharmacy services. Sustained patient volumes and healthcare utilization can support operating leverage and provide a durable base for expansion across its care network.
Read all positive factors
Aster DM Healthcare Ltd. (ASTERDM) vs. iShares MSCI India ETF (INDA)
Market Cap
₹667.44B
Dividend Yield0.53%
Average Volume (3M)57.99K
Price to Earnings (P/E)123.5
Beta (1Y)0.61
Revenue Growth15.70%
EPS Growth-2.63%
CountryIN
Employees14,016
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)6.17
Shares Outstanding871,672,400
10 Day Avg. Volume86,592
30 Day Avg. Volume57,995
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)7.55
Price to Sales (P/S)7.44
P/FCF Ratio171.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13.49
Revenue Forecast (FY)₹103.17B
Aster DM Healthcare Ltd. Business Overview & Revenue Model
Company Description
Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified ser...
How the Company Makes Money
Aster DM Healthcare Ltd. generates revenue primarily by delivering healthcare services through its owned and operated facilities. Key revenue streams typically include: (1) Inpatient hospital revenue: earnings from admissions, bed/room charges, op...
Aster DM Healthcare Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
67
Positive
Cash Flow
55
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.76B | 46.43B | 40.69B | 36.38B | 29.52B | 102.53B |
| Gross Profit | 20.68B | 14.23B | 31.31B | 27.22B | 21.68B | 73.62B |
| EBITDA | 9.19B | 9.57B | 8.27B | 5.87B | 4.73B | 15.34B |
| Net Income | 3.19B | 3.88B | 53.78B | 1.29B | 4.25B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 81.12B | 66.06B | 179.91B | 148.81B | 125.46B |
| Cash, Cash Equivalents and Short-Term Investments | 13.27B | 13.27B | 13.81B | 1.11B | 3.96B | 3.69B |
| Total Debt | 0.00 | 22.20B | 20.18B | 13.84B | 57.00B | 49.07B |
| Total Liabilities | -48.34B | 32.78B | 29.55B | 129.61B | 100.21B | 80.64B |
| Stockholders Equity | 48.34B | 45.76B | 34.28B | 45.60B | 44.48B | 39.53B |
Cash Flow | ||||||
| Free Cash Flow | 873.00M | 2.01B | 790.10M | -6.39B | 9.86B | 7.65B |
| Operating Cash Flow | 3.19B | 6.71B | 4.25B | 1.58B | 18.34B | 13.13B |
| Investing Cash Flow | -747.80M | -4.36B | 60.15B | -8.85B | -9.72B | -5.70B |
| Financing Cash Flow | -2.14B | -1.72B | -63.58B | 10.53B | -8.17B | -6.85B |
Aster DM Healthcare Ltd. Technical Analysis
Negative
615.20
Price Trends
802.73
Negative
765.07
Negative
696.34
Positive
Market Momentum
-12.42
Positive
35.94
Neutral
15.04
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ASTERDM, the sentiment is Negative. The current price of 615.2 is below the 20-day moving average (MA) of 813.97, below the 50-day MA of 802.73, and below the 200-day MA of 696.34, indicating a neutral trend. The MACD of -12.42 indicates Positive momentum. The RSI at 35.94 is Neutral, neither overbought nor oversold. The STOCH value of 15.04 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ASTERDM.
Aster DM Healthcare Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ₹377.68B | 70.48 | ― | 0.04% | 21.27% | 4.09% | |
64 Neutral | ₹667.44B | 123.52 | ― | 0.84% | 15.70% | -2.63% | |
62 Neutral | ₹386.05B | 46.93 | ― | 0.24% | 57.80% | 4.07% | |
60 Neutral | ₹695.77B | 65.84 | ― | 0.11% | 17.50% | 20.65% | |
59 Neutral | ₹1.28T | 60.32 | ― | 0.23% | 17.20% | 32.79% | |
55 Neutral | ₹987.88B | 67.13 | ― | 0.14% | 15.96% | 26.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:ASTERDM
Aster DM Healthcare Ltd.
762.20
168.10
28.29%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,790.00
1,082.63
14.05%
IN:FORTIS
Fortis Healthcare Ltd.
918.00
6.47
0.71%
IN:MAXHEALTH
Max Healthcare Institute Ltd
1,012.00
-145.69
-12.58%
IN:MEDANTA
Global Health Limited
1,460.85
62.35
4.46%
IN:NH
Narayana Hrudayalaya Ltd.
1,884.10
134.24
7.67%
Aster DM Healthcare Ltd. Corporate Events
Aster DM Quality Care Posts Q1 FY27 Earnings Call Recording Online
Aug 5, 2026
Aster DM Quality Care Limited has announced that the video and audio recording of its earnings call for the quarter ended June 30, 2026, held on August 5, 2026, is now accessible on the company’s website. This disclosure, made under SEBI lis...
Aster DM Quality Care Board Clears Q1 FY27 Unaudited Results After Clean Auditor Review
Aug 5, 2026
Aster DM Quality Care Limited’s Board of Directors has approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026, following review and recommendation by its Audit Committee. The results, prepared...
Aster DM Quality Care Schedules Q1 FY27 Earnings Call for Analysts and Investors
Jul 31, 2026
Aster DM Quality Care Limited has announced that it will hold an earnings conference call with analysts and investors on Wednesday, 5 August 2026, at 6:00 p.m. IST to discuss its unaudited financial results for the quarter ended 30 June 2026. The ...
Aster DM Healthcare Renamed Aster DM Quality Care After Amalgamation
Jul 4, 2026
Aster DM Healthcare Limited has officially changed its corporate name to Aster DM Quality Care Limited following the implementation of a court-approved Scheme of Amalgamation with Quality Care India Limited. The Registrar of Companies in Telangana...
Aster DM Healthcare to Hold Macquarie-Organised Investor Meets in Hyderabad and Bengaluru
Jun 5, 2026
Aster DM Healthcare Limited has announced that its representatives will participate in investor meetings organized by Macquarie Investor Group in Hyderabad on June 10, 2026, and in Bengaluru on June 11, 2026. The company emphasized that the sessio...
Aster DM Healthcare Publishes Investor Presentation on Financial Performance
Jun 3, 2026
Aster DM Healthcare Limited has released an investor presentation detailing the company’s financial performance and has formally notified both BSE Limited and the National Stock Exchange of India about this disclosure. The presentation has a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.